Tex. Occ. Code Section 562.106
Notification

(a)

A pharmacy shall report in writing to the board not later than the 10th day after the date of:

(1)

a permanent closing of the pharmacy;

(2)

a change of ownership of the pharmacy;

(3)

a change of the person designated as the pharmacist-in-charge of the pharmacy;

(4)

a sale or transfer of any controlled substance or dangerous drug as a result of the permanent closing or change of ownership of the pharmacy;

(5)

any matter or occurrence that the board requires by rule to be reported;

(6)

as determined by the board, an out-of-state purchase of any controlled substance;

(7)

a final order against the pharmacy license holder by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is located in another state; or

(8)

a final order against a pharmacist who is designated as the pharmacist-in-charge of the pharmacy by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is located in another state.

(a-1)

A pharmacy shall report in writing to the board not later than the 30th day before the date of a change of location of the pharmacy.

(b)

A pharmacy shall report in writing to the board a theft or significant loss of any controlled substance immediately on discovery of the theft or loss. The pharmacy shall include with the report a list of all controlled substances stolen or lost.

(c)

A pharmacy shall report in writing to the board a disaster, accident, or emergency that may affect the strength, purity, or labeling of a drug, medication, device, or other material used in the diagnosis or treatment of injury, illness, or disease, immediately on the occurrence of the disaster, accident, or emergency.

(d)

The reporting pharmacy shall maintain a copy of any notification required by this section or Section 562.053 (Reports to Board) for two years and make the copy available for inspection.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2013, 83rd Leg., R.S., Ch. 608 (S.B. 1100), Sec. 5, eff. September 1, 2013.
Acts 2015, 84th Leg., R.S., Ch. 599 (S.B. 460), Sec. 10, eff. September 1, 2015.

Source: Section 562.106 — Notification, https://statutes.­capitol.­texas.­gov/Docs/OC/htm/OC.­562.­htm#562.­106 (accessed May 18, 2024).

562.001
Definitions 562.002
Legislative Intent 562.003
Disclosure of Price 562.004
Prescription Transmitted Orally by Practitioner 562.005
Record of Dispensed Drug or Biological Product 562.006
Label 562.007
Refills 562.008
Generic Equivalent or Interchangeable Biological Product Authorized 562.009
Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product 562.010
Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product 562.011
Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product 562.012
Substitution of Dosage Form Permitted 562.013
Applicability of Subchapter 562.014
Narrow Therapeutic Index Drugs 562.015
Dispensing Directive 562.016
List of Approved Interchangeable Biological Products 562.0051
Communication Regarding Certain Dispensed Biological Products 562.052
Release of Confidential Records 562.053
Reports to Board 562.054
Emergency Refills 562.055
Report to Texas Department of Health 562.056
Practitioner-patient Relationship Required 562.057
Administration of Epinephrine 562.0061
Other Prescription Information 562.0062
Required Statement Regarding Medication Disposal 562.101
Supervision of Pharmacy 562.102
Confidential Record 562.103
Display of Licenses by Pharmacy 562.104
Toll-free Telephone Number Required 562.105
Maintenance of Records 562.106
Notification 562.107
Written Consumer Information Required 562.108
Emergency Medication Kits 562.109
Automated Pharmacy Systems 562.110
Telepharmacy Systems 562.112
Practitioner-patient Relationship Required 562.0141
Transplant Immunosuppressant Drug Product Selection Prohibited 562.0142
Adoption of Rules 562.151
Definitions 562.152
Compounding for Office Use 562.153
Requirements for Office Use Compounding 562.154
Distribution of Compounded and Prepackaged Products to Certain Pharmacies 562.155
Compounding Service and Compounded Drug Products 562.156
Compounded Sterile Preparation 562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies 562.1011
Operation of Class C Pharmacy in Certain Rural Hospitals 562.1045
Linking Internet Sites 562.1085
Unused Drugs Returned by Certain Pharmacists 562.1086
Limitation on Liability
Green check means up to date. Up to date

Accessed:
May 18, 2024

§ 562.106’s source at texas​.gov